A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.

NCT00989625 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: This is a pharmacokinetic study (Treximet)
DRUG: This is a pharmacokinetic study (Treximet)
DRUG: This is a pharmacokinetic study (Treximet)

Sponsor

GlaxoSmithKline